COSCIENS Biopharma Inc. Announces Successful Phase 1 Results Supporting Initiation of Phase 2a Clinical Efficacy Trial with Avenanthramides as a Potential Anti-Inflammatory Product
13 mars 2025 07h55 HE
|
COSCIENS Biopharma Inc.
No significant clinical adverse event observed in Phase 1clinical studyPharmacokinetic profile established and range of doses selected for Phase 2a Clinical Efficacy StudyFirst patient expected to be...
YPrime Earns Prestigious EcoVadis Rating, Strengthening Commitment to Sustainable and Responsible Clinical Research
12 mars 2025 08h00 HE
|
Y-Prime, LLC
YPrime earns prestigious EcoVadis rating, reinforcing commitment to sustainable clinical research.
Neurona Unveils Phase 3 EPIC Study for NRTX-1001 Cell Therapy in Epilepsy
20 févr. 2025 12h00 HE
|
Neurona Therapeutics
Neurona Unveils Phase 3 EPIC Study for NRTX-1001 Cell Therapy in Epilepsy
Plus Therapeutics Appoints Dr. Michael Rosol as Chief Development Officer
20 févr. 2025 07h30 HE
|
Plus Therapeutics Inc.
Plus Therapeutics Appoints Dr. Michael Rosol as Chief Development Officer
YPrime Releases Reimagined eCOA Automated Data Change Form for More Efficient Clinical Trial Data Management
04 févr. 2025 08h00 HE
|
Y-Prime, LLC
YPrime launches eCOA Automated Data Change Form, reimagining clinical trial data management with enhanced efficiency and accuracy.
Jupiter Neurosciences Partners with Zina Biopharmaceuticals to Advance Phase 2a Parkinson’s Trial
30 janv. 2025 08h00 HE
|
Jupiter Neurosciences, Inc.
Jupiter, Florida, Jan. 30, 2025 (GLOBE NEWSWIRE) -- Jupiter Neurosciences, Inc. (NASDAQ: JUNS) (“Jupiter” or the “Company”), a clinical-stage pharmaceutical company developing JOTROL™, a patented...
[Latest] Global Clinical Trial Outsourcing Market Size/Share Worth USD 91,210.1 Million by 2033 at a 7.46% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)
15 janv. 2025 08h10 HE
|
Custom Market Insights
Austin, TX, USA, Jan. 15, 2025 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Clinical Trial Outsourcing Market Size, Trends and Insights By Services...
YPrime’s Karl McEvoy Appointed as eCOA Consortium Industry Co-Director for 2025
14 janv. 2025 08h00 HE
|
Y-Prime, LLC
YPrime's Dr. Karl McEvoy, VP eCOA & Patient Technologies, has been appointed Industry Co-Director of the Critical Path Institute (C-Path) eCOA Consortium
Franklin Access (Formerly Franklin Wireless) Successfully Defends Shareholder Litigation
24 déc. 2024 13h00 HE
|
Franklin Wireless Corporation
SAN DIEGO, Dec. 24, 2024 (GLOBE NEWSWIRE) -- Franklin Access is pleased to announce a significant legal victory in its shareholder litigation, “In re Franklin Wireless Corp. Derivative Litigation”,...
BIOA BREAKING NEWS: BFA Law Announces an Investigation into BioAge Labs, Inc. after Stock Plummets 76% -- Contact the Firm if You Lost Money (NASDAQ:BIOA)
10 déc. 2024 12h49 HE
|
Bleichmar Fonti & Auld
BioAge Labs, Inc. investors that lost money are encouraged to contact BFA Law about its securities fraud investigation into the Company.